Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Kijima, Hiroaki ^a   Sawada, Tokihiko ^a   Tomosugi, Naohisa ^b   Kubota, Keiichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; HEPCIDIN; IRON; MESSENGER RNA; TRANSFERRIN RECEPTOR 2; ANTIMICROBIAL CATIONIC PEPTIDE; TUMOR MARKER;

ADULT; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE REPRESSION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON BINDING CAPACITY; IRON OVERLOAD; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; AGED; ANALYSIS OF VARIANCE; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PATHOLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL;

AGED; ANALYSIS OF VARIANCE; ANTIMICROBIAL CATIONIC PEPTIDES; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 45849140833     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-167     Document Type: Article

References (26)

1. Ferlay J Bray F Pisani P Parkin DM: GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. Lyon: IARC Press 2001
2. Fattovich G Stroffolini T Zagni I Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 2004, 127(5 Suppl 1):S35-S50. 10.1053/j.gastro.2004.09.014 15508101
3. Deugnier Y Turlin B Loréal O: Iron and neoplasia. J Hepatol 1998, 28:21-25. 10.1016/S0168-8278(98)80371-1 9575445
4. Hentze MW Muckenthaler MU Andrews NC: Balancing acts: molecular control of mammalian iron metabolism. Cell 2004, 117:285-297. 10.1016/ S0092-8674(04)00343-5 15109490
5. Di Bisceglie AM Axiotis CA Hoofnagle JH Bacon BR: Measurement of iron status in patients with chronic hepatitis. Gastroenterology 1992, 102:2108-213. 1587431
6. Metwally MA Zein CO Zein NN: Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 2004, 99:286-291. 10.1111/ j.1572-0241.2004.04049.x 15046219
7. Yamamoto M Iwasa M Iwata K Kaito M Sugimoto R Urawa N Mifuji R Konishi M Kobayashi Y Adachi Y: Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2007, 22:498-503. 10.1111/j.1440-1746.2006.04548.x 17376040
8. Nicoras G Viatte L Bennoun M Beaumont C Kahn A Vaulont S: Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002, 29:327-335. 10.1006/bcmd.2002.0573 12547223
9. GanzAT: Hepcidin: a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102:783-788. 10.1182/ blood-2003-03-0672 12663437
10. Ganz T Nemeth E: Iron Imports IV: Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointestinal Liver Physiol 2006, 290:G199-G203. 10.1152/ajpgi.00412.2005 16407589
11. Pietrangelo A TrTutwein C: Mechanism of disease: the role of hepcidin in iron homeostasis - implications for hemochromatosis and other disorders. Nat Clin Prac Gastroenterol Hepatol 2004, 1:39-45. 10.1038/ncpgasthep0019
12. Frazer DM Inglis HR Wilkins SJ Millard KN Steele TM McLaren GD McKie AT Vulpe CD Anderson GJ; Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 2004, 53:1509-1515. 1774251 15361505 10.1136/gut.2003.037416
13. Nicolas G Chauvet C Viatte L Danan JL Bigard X Devaux I Beaumont C Kahn A Vaulont S: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110:1037-1044. 151151 12370282
14. Iso Y Sawada T Okada T Kubota K: Loss of E-cadherin mRNA and gain of osteopontin mRNA are useful markers for detecting early recurrence of HCV-related hepatocellular carcinoma. J Surg Oncol 2005, 92:304-311. 10.1002/jso.20388 16299806
15. Tomosugi N Kawabata H Watanabe R Higuchi M Yamaya H Umehara H Ishikawa I: Detection of serum hepcidin in renal failure and inflammation by using proteinchip system. Blood 2006, 108:1381-1387. 10.1182/ blood-2005-10-4043 16621968
16. Laftah AII Ramesh B Simpson R Solanky N Bahram S Schümann K Debnam ES Srai SK: Effect of hepcidin on intestinal iron absorption in mice. Blood 2004, 103:3940-3944. 10.1182/blood-2003-03-0953 14751922
17. Kuston MD Oukka M Koss LM Aydemir F Wessling-Resnick M: Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA 2005, 102:1324-1328. 547844 15665091 10.1073/pnas.0409409102
18. Fargion S Mandelli C Piperno A Cecana B Fracanzani AL Fraquelli M Bianchi PA Fiorelli G Conte D: Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992, 15:655-659. 10.1002/hep.1840150417 1312985
19. Le NT Richardson DR: The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 2002, 1603:31-46. 12242109
20. Weizer-Stern O Adamsky K Margalit O Ashur-Febian O Givol D Amariglio N Rechavi G: Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53. Br J Haematol 2007, 138:253-262. 10.1111/j.1365-2141.2007.06638.x 17593032
21. Levine AJ Momand J Finlay CA: The p53 tumour suppressor gene. Nature 1991, 351:453-456. 10.1038/351453a0 2046748
22. Laurent-Puig P Zuckman-Rossi J: Genetics of hepatocellular tumors. Oncogene 2006, 25:3778-3786. 10.1038/sj.onc.1209547 16799619
23. Wessling-Resnic M: Iron imports III: Transfer of iron from mucosa into circulation. Am J Physiol Gastrointest Liver Physiol 2006, 290:G1-G6. 10.1152/ajpgi.00415.2005 16354771
24. Ganz T Nemeth E: Iron Imports IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointestinal Liver Physiol 2006, 290:G199-G203. 10.1152/ajpgi.00412.2005 16407589
25. Kawabata H Tong X Kawanami T Wano Y Hirose Y Sugai S Koeffler HP: Analyses for binding of the transferrin family of proteins to the transferrin receptor 2. Br J Haematol 2004, 127:464-473. 10.1111/ j.1365-2141.2004.05224.x 15521925
26. Wallace DF Summerville L Lusby PE Subramanian VN: First phenotypic description of transferrin receptor 2 knockout mouse, and role of hepcidin. Gut 2005, 54:980-986. 10.1136/gut.2004.062018 15951546